Coradi Tonon Caroline, de Souza Rastelli Alessandra Nara, Bodahandi Chathuna, Ashraf Shoaib, Hasan Tayyaba, Xu QianFeng, Greer Alexander, Lyons Alan M
Wellman Center for Photomedicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Department of Restorative Dentistry, School of Dentistry, Araraquara, Sao Paulo State University-UNESP, Araraquara, Brazil.
Photochem Photobiol. 2025 May-Jun;101(3):592-608. doi: 10.1111/php.14021. Epub 2024 Oct 10.
Superhydrophobic antimicrobial photodynamic therapy (SH-aPDT) is advantageous wherein airborne singlet oxygen (O) is delivered from a device tip to kill a biofilm with no photosensitizer exposure and no bacterial selectivity (Gram + or Gram -). For effective treatment of periodontitis, the frequency of treatment as well as the optical light fluence required is not known. Thus, we sought to determine whether single or repeated SH-aPDT treatments would work best in vivo using two fluence values: 60 and 125 J/cm. We assessed the efficacy of three protocols: single treatment; interval treatments (days 0, 2, and 7); and consecutive treatments (days 0, 1, and 2). After 30 days of evaluation, we found that, SH-aPDT in 3 consecutive treatments significantly decreased Porphyromonas gingivalis levels compared to single and interval SH-aPDT treatments, as well as SRP-chlorhexidine (CHX) controls (p < 0.05). Notably, clinical parameters also improved (p < 0.05), and histological and stereometric analyses revealed that consecutive SH-aPDT treatments were the most effective for promoting healing and reducing inflammation. Our study shows what works best for SH-aPDT, while also demonstrating SH-aPDT advantages to treatment of periodontitis including no bacterial selectivity (Gram + or Gram -) and preventing the development of bacterial resistance.
超疏水抗菌光动力疗法(SH-aPDT)具有优势,其中空气中的单线态氧(O)从设备尖端释放,可在不暴露光敏剂且无细菌选择性(革兰氏阳性或革兰氏阴性)的情况下杀死生物膜。对于牙周炎的有效治疗,治疗频率以及所需的光通量尚不清楚。因此,我们试图确定单次或重复的SH-aPDT治疗在体内使用60和125 J/cm这两个光通量值时哪种效果最佳。我们评估了三种方案的疗效:单次治疗;间隔治疗(第0、2和7天);连续治疗(第0、1和2天)。经过30天的评估,我们发现,与单次和间隔SH-aPDT治疗以及SRP-氯己定(CHX)对照相比,连续3次SH-aPDT治疗显著降低了牙龈卟啉单胞菌水平(p < 0.05)。值得注意的是,临床参数也有所改善(p < 0.05),组织学和立体测量分析表明,连续SH-aPDT治疗在促进愈合和减轻炎症方面最有效。我们的研究表明了SH-aPDT的最佳治疗方式,同时也证明了SH-aPDT在治疗牙周炎方面的优势,包括无细菌选择性(革兰氏阳性或革兰氏阴性)以及防止细菌耐药性的产生。